Award NoticeActiveSPE2D221R0116
Levalbuterol HCL Solution
DEPT OF DEFENSE / DEFENSE LOGISTICS AGENCY / DLA TROOP SUPPORTKey dates?
- Posted?
- Aug 31, 2022
- Response deadline?
- —
- Archive date?
- Aug 31, 2028
- Archive type?
- autocustom
Classification?
- Notice type?
- Award Notice
- Base type?
- Solicitation
- Set-aside?
- —
- Set-aside code?
- —
- PSC?
- 6505
NAICS?
- 325412Pharmaceutical Preparation Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--
Issuing office?
- Department?
- DEPT OF DEFENSE
- Sub-tier?
- DEFENSE LOGISTICS AGENCY
- Office?
- DLA TROOP SUPPORT
- Office code?
- —
- Organization type?
- OFFICE
- Office address?
- PHILADELPHIA, PA, 19111, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- Runcorn
- State?
- Cheshire
- Zip?
- 73fa
- Country?
- GBR
Contacts?
- Phyllis Daraioprimary
Description?
Contract Award for Leavalbuterol HCL Solution SPE2D222D0146
Award?
- Number?
- SPE2D222D0146
- Amount?
- $5,687,207.30
- Date?
- Aug 31, 2022
- Awardee?
- Teva Pharmaceuticals USA, Inc. NJ 07054-1120 USA
- UEI?
- —
- Awardee address?
- —
Other notices in this solicitation?
- SolicitationLevalbuterol HCL SolutionAug 5, 2025LATEST
- SolicitationLevalbuterol HCL SolutionAug 1, 2024
- Award NoticeLevalbuterol HCL SolutionAug 23, 2023
- Award NoticeLevalbuterol HCL SolutionJul 31, 2023
- SolicitationLevalbuterol HCL SolutionApr 1, 2022
- SolicitationLevalbuterol HCL SolutionMar 14, 2022
- SolicitationLevalbuterol HCL SolutionMar 3, 2022
- SolicitationLevalbuterol HCL SolutionFeb 25, 2022
- SolicitationLevalbuterol HCL SolutionFeb 7, 2022
- SolicitationLevalbuterol HCL SolutionFeb 3, 2022
- PresolicitationLevalbuterol HCL SolutionSep 30, 2021
Similar open contracts
Similar past awards
Metadata?
- Notice ID?
- 1f2dab28104a4d22a1fe3d5ab06aea9d
- Full path?
- DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
- Office code?
- —
- Ingested?
- May 2, 2026
- Updated?
- May 2, 2026
Raw record
{
"CGAC": "097",
"City": "PHILADELPHIA",
"Link": "https://sam.gov/workspace/contract/opp/1f2dab28104a4d22a1fe3d5ab06aea9d/view",
"Sol#": "SPE2D221R0116",
"Type": "Award Notice",
"State": "PA",
"Title": "Levalbuterol HCL Solution",
"Active": "Yes",
"Award$": "5687207.30",
"Office": "DLA TROOP SUPPORT",
"PopZip": "73fa",
"Awardee": "Teva Pharmaceuticals USA, Inc. NJ 07054-1120 USA",
"PopCity": "Runcorn",
"ZipCode": "19111",
"AAC Code": "SPE2D2",
"BaseType": "Solicitation",
"NoticeId": "1f2dab28104a4d22a1fe3d5ab06aea9d",
"PopState": "Cheshire",
"SetASide": "",
"Sub-Tier": "DEFENSE LOGISTICS AGENCY",
"AwardDate": "2022-08-31",
"FPDS Code": "97AS",
"NaicsCode": "325412",
"PopCountry": "GBR",
"PostedDate": "2022-08-31 13:41:07.754-04",
"ArchiveDate": "2028-08-31",
"ArchiveType": "autocustom",
"AwardNumber": "SPE2D222D0146",
"CountryCode": "USA",
"Description": "Contract Award for Leavalbuterol HCL Solution SPE2D222D0146",
"SetASideCode": "",
"OrganizationType": "OFFICE",
"PopStreetAddress": "",
"ResponseDeadLine": "",
"PrimaryContactFax": "",
"AdditionalInfoLink": "",
"ClassificationCode": "6505",
"PrimaryContactEmail": "Phyllis.Daraio@dla.mil",
"PrimaryContactPhone": "2157377941",
"PrimaryContactTitle": "",
"SecondaryContactFax": "",
"Department/Ind.Agency": "DEPT OF DEFENSE",
"SecondaryContactEmail": "",
"SecondaryContactPhone": "",
"SecondaryContactTitle": "",
"PrimaryContactFullname": "Phyllis Daraio",
"SecondaryContactFullname": ""
}